Matinas BioPharma's total assets for Q2 2025 were $11.42M, a decrease of -5.08% from the previous quarter. MTNB total liabilities were $3.75M for the fiscal quarter, a -34.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.